发明名称 |
RADIOLABELED ANALOG(S) OF COMPOUND 0118 AND USE THEREOF IN CONNECTION WITH PET AND/OR SPECT IMAGING TO DETERMINE WHETHER A PHARMACEUTICAL CONTAINING COMPOUND 0118 IS A CANDIDATE CANCER TREATMENT FOR A PATIENT |
摘要 |
A method for determining whether compound 0118 is a candidate treatment for a patient includes processing, via a processor, image data of tissue of interest of a patient including a cancer to determine whether a radiolabeled analog of compound 0118 is present in the tissue of interest represented in the image data and generating a signal indicating that compound 0118 is a candidate treatment for the patient in response to the determining that the radiolabeled analog of compound 0118 is present in a predetermined amount in the tissue of interest represented in the image data, wherein the presence of the radiolabeled analog of compound 0118 in the tissue of interest indicates presence of a sub-type of cancer having a galectin-1 molecular target, which is a sub-type of treatable by compound 0118. |
申请公布号 |
WO2013186690(A2) |
申请公布日期 |
2013.12.19 |
申请号 |
WO2013IB54744 |
申请日期 |
2013.06.10 |
申请人 |
KONINKLIJKE PHILIPS N.V. |
发明人 |
LAEPPCHEN, TILMAN;GRUELL, HOLGER;ROBILLARD, MARC STEFAN;LUB, JOHAN |
分类号 |
A61K49/00 |
主分类号 |
A61K49/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|